
Gynecologic Oncologist

No OPD information available
Ovarian Cancer
Cervical Cancer
Endometrial Cancer
Oophorectomy
Ovarian Carcinosarcoma
Adult Soft Tissue Sarcoma
Appendix Cancer
Ascites
Bowel Incontinence
Brachial Plexopathy
Cervical Dysplasia
Gestational Trophoblastic Disease
Horner Syndrome
Hydatidiform Mole
Hysterectomy
Intrauterine Device Insertion
Necrosis
Retinoblastoma
Salpingo-Oophorectomy
Testicular Cancer
Urinary Incontinence
Vaginal Cancer
Vulvar Cancer
Orla M. Mcnally is a doctor who helps people with different types of cancer like ovarian, cervical, and endometrial cancer. They also treat conditions like urinary incontinence and testicular cancer. Orla M. Mcnally is skilled in surgeries like oophorectomy and salpingo-oophorectomy.
Patients trust Orla M. Mcnally because they communicate well and listen to their concerns. They explain things in a way that is easy to understand and make sure patients feel comfortable and cared for.
To stay updated with the latest medical knowledge, Orla M. Mcnally reads research articles and attends conferences. This helps them provide the best care possible to their patients.
Orla M. Mcnally works well with other medical professionals, like nurses and surgeons. They collaborate to make sure patients receive comprehensive care and treatment.
One way Orla M. Mcnally has made a positive impact is through their research on risk-reducing surgeries for women at high risk of gynecological cancers. Their work has helped improve outcomes for these patients.
Orla M. Mcnally has also been involved in a clinical trial comparing different approaches to treating early-stage endometrial cancer. This research could lead to better treatment options for patients in the future.
Overall, Orla M. Mcnally is a caring and skilled doctor who is dedicated to helping patients with cancer and other conditions. Their commitment to staying informed and working collaboratively with other medical professionals ensures that patients receive the best possible care.
Enrollment Status: Recruiting
Published: April 03, 2025
Intervention Type: Procedure
Study Drug:
Study Phase: Phase 3
